In the United States, there is significant variation in the aggressiveness and quality of end-oflife care. Up to 50% of Medicare beneficiaries dying with cancer receive aggressive care at the end of life. High levels of aggressive care at the end of life are incongruous with patient preferences and regions with high rates of aggressive end-of-life care have been shown to have poorer outcomes. We aim, for the first time in the literature, to quantify the proportion of bladder cancers patients receiving aggressive end-of-life care.
INTRODUCTION AND OBJECTIVES:
In the United States, there is significant variation in the aggressiveness and quality of end-oflife care. Up to 50% of Medicare beneficiaries dying with cancer receive aggressive care at the end of life. High levels of aggressive care at the end of life are incongruous with patient preferences and regions with high rates of aggressive end-of-life care have been shown to have poorer outcomes. We aim, for the first time in the literature, to quantify the proportion of bladder cancers patients receiving aggressive end-of-life care.
METHODS: We used Surveillance, Epidemiology, and End Results (SEER)-Medicare data to conduct a population-based study of patients who were diagnosed with bladder cancer and died between 2008-2014. Our primary outcome was receipt of aggressive end-of-life care, defined as any of the following occuring in the last 30 days of life: >1 hospital admission, >1 emergency department (ED) visit, any intensive care unit (ICU) admission, receipt of chemotherapy in the last 14 days of life, or death in an acute-care hospital. We examined demographic and clinicopathologic determinants of receiving aggressive end-of-life care. We also assessed for an association between receipt of palliative care and likelihood of receiving aggressive end-of-life care.
RESULTS: Among 13,253 patients, 6861 (52%) experienced at least one measure of aggressive end-of-life care. The most common measure was in-hospital death, at 30%. In the last month of life, 28% of the cohort was admitted to the ICU, 17% had more than 1 ED visit, and 13% had more than one hospital admission ( Figure) .
CONCLUSIONS: Aggressive end-of-life care is prevalent among patients dying with bladder cancer, with over half receiving aggressive care in the last month of life. Over 30% of all bladder cancer patients died in the hospital setting. Future studies must address how patient, physician, and systems factors impact these rates, with the goal of decreasing unnecessary or unwanted aggressive care.
Source of Funding: None
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INTRODUCTION AND OBJECTIVES: In the era of digital-data, the 'web' has become the primary source where individuals draw healthcare information. The aim of the present study is to determine worldwide public interest in prostate cancer (PCa) treatments, their penetrance and variation, and how they compare over time.
METHODS: Worldwide search-engine trends analysis included electronic Google queries from people who searched PCa treatment options from January 2004 to August 2018, worldwide. Join-point regression (JPR) was performed. Comparison annual relative search volume (ARSV), average annual percentage change (AAPC) and temporal patterns were analysed to assess loss or gain of interest. Evaluations were made regarding (1) interest in PCa treatments; (2) comparison regarding people interest (3) the impact of the U.S.RESULTS: The mean ARSV for 'prostatectomy' was 73% in 2004 and decreased reaching a nadir of 36% in 2014 (APC: -7.2%; 95% CI -7.8, -6.7; p<0.01). Similarly, a decreased interest was recorded for 'radiation therapy' (AAPC:-3.2%, p[0.1), 'HIFU' (AAPC:-2.3%, p[0.1), 'hormonal therapy' (AAPC:-11.6%, p<0.01), 'ablation therapy' (AAPC:-4.1%, p<0.01), 'cryotherapy' (AAPC:-9.9%, p< 0.01), brachytherapy (AAPC:-8.3%, p<0.01). A steep interest in 'active surveillance' (AS) was found (AAPC:þ14.2%, p<0.01) and 'focal therapy' (AAPC:þ27.5%, p<0.01). When trends where compared before and after NCCN and USPSTF recommendation, a consistent decrease of all the treatments option was found, while interest in Focal Therapy and AS showed an augmented mean ARSV (þ19.6 and þ31.6 respectively).
CONCLUSIONS: People are increasingly searching the web for PCa treatment options. A parallel decrease of interest was found for the non-monitoring treatments, except for Focal Therapy,while an important growth of appeal has been recorded for AS. Understanding people inquisitiveness together with their degree of knowledge could be supportive to guide counselling in the decision-making process and put effort in certifying patient information, avoiding them to fall in the pernicious trap of 'fake news'.
Source of Funding: none
MP33-09 BARRIERS AND FACILITATORS OF HEALTH CARE UTILIZATION AMONG YOUNG MEN IN THE UNITED STATES
Mohammed Said*, Atlanta, GA; Frances Kim, Atlanta, GA; Michelle Sheng, Atlanta, GA; R Craig Sineath, Atlanta, GA; Akanksha Mehta, Atlanta, GA INTRODUCTION AND OBJECTIVES: Men are 2.5 times less likely than women to seek medical care. We investigated various independent demographic and socio-economic variables that could influence healthcare-seeking behaviors of young men in the U.S. at a population level.
METHODS: We abstracted data on age, race/ethnicity, marital status, education level, employment status, income level, insurance status, and family size for 18-44 year-old respondents of the 2013-2015 National Survey of Family Growth (NSFG) Male Respondent Survey, and assessed the frequency with which the respondents accessed preventative, diagnostic, or curative care during the 12-month period preceding survey participation. Weighted logistic regression models were used to determine the association between the covariates of interest, and the use of health services. Estimates were based on sampling weights designed to produce unbiased estimates for the U.S. population, and significance was set at p < 0.05. SAS v9.4 was used for all statistical analyses.
RESULTS: Of the 3,882 respondents who completed the survey, 2,815 (73%) reported a reason to seek medical care, and 2,614 (67%) were successfully able to do so. The majority of these men (74%) visited a preventive care facility, while 23% sought emergency/urgent care. Among men who did not seek medical care, the most common reason was "did not need to see a doctor" (84%), followed by "could not afford to pay for a visit" (9%). 33% of the overall cohort reported an interruption in insurance coverage in the preceding 12 months. In univariate models, race/ethnicity, education, employment status, income, and insurance status were significant predictors of use of healthcare services. In multivariate models, race/ethnicity and insurance status remained the only significant predictors of use of healthcare services. Black (OR 0.5, 95% CI 0.27-0.93) and Hispanic (OR 0.47, 95% CI 0.28-0.76) men were less likely to utilize healthcare services, compared to Caucasian men (p<0.01). Uninsured respondents (OR 0.15, 95% CI 0.09-0.25) and Medicaid participants (OR 0.74, 95% CI 0.36-1.51) were less likely to utilize healthcare services, compared to those covered by private health insurance (p<0.01).
CONCLUSIONS: In this study, race/ethnicity and insurance status emerged as significant barriers to the use of healthcare services among men who identified healthcare needs. Healthcare providers should be mindful of these factors in order to maximize the clinical value of each health care visit for affected patients.
